Levy Adam Scott Insider Trading Activity

Average Profitability
4.18%
Insider Buys Quantity
2
Insider Buys Sum
$101,500.00
Insider Sells Quantity
5
Insider Sells Sum
$1.77M

Insider Activity of Levy Adam Scott

According to the SEC Form 4 filings, Levy Adam Scott, being in a position of

  1. CFO and Secretary at Mineralys Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 130282 shares for $5.71M,
    over all time since 2024-06-11, has bought 0 shares, and sold 365319 shares for $9.16M.

Biography of Levy Adam Scott

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,709,4392100

Comparison of Insiders on Amount of Buys and Sells

2026-01-12SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,758
0.0158%
$32.14$345,723-17.94%
2025-11-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
119,524
0.2128%
$44.88$5.36M-41.22%
2025-10-13SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,758
0.0158%
$42.01$451,984-33.96%
2025-07-30SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
59,925
0.0936%
$14.76$884,372+105.18%
2025-07-29SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
807
0.0012%
$14.00$11,302+114.19%
2025-07-28SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
12,946
0.0205%
$14.04$181,803+118.6%
2025-07-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,758
0.0165%
$14.45$155,454+105.31%
2025-04-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,757
0.0171%
$12.06$129,684+109.4%
2025-01-13SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,757
0.0211%
$9.10$97,864+63.68%
2024-10-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,757
0.023%
$13.57$146,004+1.62%
2024-07-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
10,757
0.0222%
$13.14$141,394-3.61%
2024-06-11SaleMineralys Therapeutics, Inc.
MLYS
CFO and Secretary
96,815
0.1971%
$12.94$1.25M-2.89%
2018-02-13PurchaseViridian Therapeutics, Inc.
VRDN
Chief Business Officer
18,180
0.0686%
$5.50$99,990+6.91%
2017-06-22PurchaseViridian Therapeutics, Inc.
VRDN
Chief Business Officer
200
0.0009%
$7.55$1,510+1.46%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.